NASDAQ · Drug Manufacturers - Specialty & Generic

Organogenesis Holdings Inc. - Class A (ORGO) Stock

$1.29 +0.78% NASDAQ: ORGO Healthcare

Valuation

MetricValue
Price$1.29
Market Cap$165.99M
P/E Ratio-1.62
P/B Ratio0.59
P/S Ratio0.37
EPS (TTM)$0.15
52-Week High$7.08
52-Week Low$1.26
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-24.23%
ROA-22.20%
ROCE-8.34%
Gross Margin9.95%
Operating Margin9.95%
Net Margin-19.76%
Debt/Equity0.23
Current Ratio3.62

Annual Financials (USD)

Metric20212022202320242025
Revenue$467.0M$451.0M$433.0M$482.0M$563.0M
Operating Profit$72.0M$22.0M$13.0M$-1.0M$56.0M
Net Profit$94.0M$16.0M$5.0M$1.0M$37.0M
EPS$0.70$0.12$0.04$-0.01$0.15
Op Margin15.4%5.0%2.9%-0.3%9.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$443.0M$449.0M$460.0M$498.0M$599.0M
Total Liabilities$202.0M$184.0M$181.0M$113.0M$165.0M
Cash$114.0M$102.0M$104.0M$136.0M$94.0M
Borrowings$132.0M$124.0M$119.0M$43.0M$133.0M

Latest News

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026 GlobeNewswire · Jul 9, 2026 Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis GlobeNewswire · Jul 6, 2026 Is Organogenesis Holdings Inc. (ORGO) Losing Momentum? BTIG Pulls Buy Rating After Q1 Update Insider Monkey · May 20, 2026 Spotlight On Penny Stocks To Consider In May 2026 Simply Wall St. · May 14, 2026 Undervalued Small Caps With Insider Buying To Watch In May 2026 Simply Wall St. · May 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$62.0M$25.0M$31.0M$14.0M$-10.0M
Investing Cash Flow$-62.0M$-68.0M$-49.0M$-20.0M$-28.0M
Financing Cash Flow$-1.0M$1.0M$0$-24.0M$-16.0M
Net Cash Flow$30.0M$-11.0M$1.0M$32.0M$-42.0M
Free Cash Flow$31.0M$-9.0M$7.0M$4.0M$-24.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-40.61
FCF Yield12.18%
Quick Ratio3.00
Interest Coverage0.00
Return 1Y-51.20%
Return 3Y-41.45%
Return 5Y-85.16%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANGOAngioDynamics, Inc. $11.52 +2.58% -17.17 $476.15M 0.00%
BCYCBicycle Therapeutics plc $4.22 +0.24% -1.34 $292.84M 0.00%
CMPXCompass Therapeutics, Inc. $0.99 +0.98% -2.06 $178.83M 0.00%
EBSEmergent BioSolutions Inc. $7.06 +3.67% -1.84 $364.27M 0.00%
EOLSEvolus, Inc. $7.73 -0.90% -14.94 $509.06M 0.00%

About Organogenesis Holdings Inc. - Class A

Organogenesis Holdings Inc. - Class A is led by CEO Gary S. Gillheeney, employs 869 people, headquartered in US, publicly traded since 2017.

Organogenesis Holdings Inc. - Class A (ORGO) stock trades at $1.29 with a market capitalization of $165.99M. The stock is valued at a price-to-earnings (P/E) ratio of -1.62, price-to-book of 0.59, price-to-sales of 0.37. Over the past 52 weeks the stock has ranged between $1.26 and $7.08, and currently trades 81.8% below its 52-week high.

On profitability, Organogenesis Holdings Inc. - Class A generates a return on equity (ROE) of -24.23%, return on capital employed of -8.34%, an operating margin of 9.95%, a net profit margin of -19.76%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides